| Predicate |
Object |
| contentType |
Journal Article |
| endingPage |
39 |
| issn |
1176-6328 |
| pageRange |
229-39 |
| publicationName |
Neuropsychiatric Disease and Treatment |
| startingPage |
229 |
| bibliographicCitation |
Hayes KC. Impact of extended-release dalfampridine on walking ability in patients with multiple sclerosis. Neuropsychiatr Dis Treat. 2011;7():229–39. PMID: 21573085; PMCID: PMC3090287. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8afd9bf7c7a730c2b34f950807b91ee8 |
| date |
201104 |
| identifier |
https://pubmed.ncbi.nlm.nih.gov/PMC3090287
https://doi.org/10.2147/ndt.s10469
https://pubmed.ncbi.nlm.nih.gov/21573085 |
| isPartOf |
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/33193
https://portal.issn.org/resource/ISSN/1176-6328 |
| language |
English |
| source |
https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/ |
| title |
Impact of extended-release dalfampridine on walking ability in patients with multiple sclerosis |
| discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1727
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8532
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5462222
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_9d79293d1b9800c3c1d4fa39a32baa83
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71739 |